Patel Samir Rashmikant — SEC insider filings

SEC reporting owner CIK 1702447. 19 insider filings on record with FilingPulse; latest filed 2026-10-16.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2021-10-20 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Akari Therapeutics Plc (AKTX)Director16——35
CytoDyn Inc. (CYDY)Director3——13

Insider filings — Patel Samir Rashmikant

FiledFormIssuerReported transactionsSource
2026-10-164Akari Therapeutics Plc (AKTX)Grant/award (A): 6,300 @ $7.90 · Grant/award (A): 2,236 @ $7.90 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-07-174Akari Therapeutics Plc (AKTX)Option exercise (M): 1,209 @ $8 · Option exercise (M): 15,466 @ $0.00 · Option exercise (M): 5,799 @ $0.00 · Option exercise (M): 1,209 (derivative) @ $32 · Option exercise (M): 15,466 (derivative) @ $16.16 · Option exercise (M): 5,799 (derivative) @ $16.16EDGAR
2025-12-184Akari Therapeutics Plc (AKTX)Purchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 231,997 (derivative) · Purchase (P): 231,997 (derivative) @ $0.40EDGAR
2025-03-244Akari Therapeutics Plc (AKTX)Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-104Akari Therapeutics Plc (AKTX)Grant/award (A): 406,250 @ $1.12 · Grant/award (A): 406,250 (derivative) @ $1.12 · Grant/award (A): 406,250 (derivative) @ $1.12EDGAR
2025-01-074Akari Therapeutics Plc (AKTX)Grant/award (A): 208,000 @ $0.00 · Grant/award (A): 152,672,000 (derivative) @ $0EDGAR
2024-12-304Akari Therapeutics Plc (AKTX)Grant/award (A): 3,200,000 @ $0.00 · Grant/award (A): 400,000 @ $0.00EDGAR
2024-12-274Akari Therapeutics Plc (AKTX)Grant/award (A): 7,500,000 @ $0.00EDGAR
2024-12-264Akari Therapeutics Plc (AKTX)Grant/award (A): 1,400,000 @ $0.00EDGAR
2024-12-264Akari Therapeutics Plc (AKTX)Grant/award (A): 1,400,000 @ $0.00EDGAR
2024-12-034Akari Therapeutics Plc (AKTX)Grant/award (A): 419,286,000 @ $0.00 · Grant/award (A): 162,604,000 (derivative) @ $0 · Grant/award (A): 419,286,000 (derivative) @ $0.00EDGAR
2024-11-184Akari Therapeutics Plc (AKTX)Grant/award (A): 1,404,622,000EDGAR
2024-11-014Akari Therapeutics Plc (AKTX)Grant/award (A): 79,684,000 (derivative) @ $0EDGAR
2024-10-024Akari Therapeutics Plc (AKTX)Grant/award (A): 175,080,000 (derivative) @ $0EDGAR
2024-07-024Akari Therapeutics Plc (AKTX)Grant/award (A): 91,396,000 @ $0EDGAR
2024-06-044Akari Therapeutics Plc (AKTX)Grant/award (A): 1,326,258,000 @ $0.00 · Grant/award (A): 1,326,258,000 (derivative) @ $0.00EDGAR
2021-11-304/ACytoDyn Inc. (CYDY)Disposition to issuer (D): 225,000 (derivative) · Grant/award (A): 112,500 (derivative) · Disposition to issuer (D): 225,000 (derivative) · Grant/award (A): 225,000 (derivative) · Disposition to issuer (D): 12,329 (derivative) · Grant/award (A): 12,329 (derivative)EDGAR
2021-11-294CytoDyn Inc. (CYDY)Disposition to issuer (D): 225,000 (derivative) · Grant/award (A): 93,750 (derivative) · Disposition to issuer (D): 225,000 (derivative) · Grant/award (A): 225,000 (derivative) · Disposition to issuer (D): 12,329 (derivative) · Grant/award (A): 12,329 (derivative)EDGAR
2021-10-204CytoDyn Inc. (CYDY)Grant/award (A): 225,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-10-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702447 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs